Status:
COMPLETED
Adenosine vs AF Termination for Paroxysmal AF Ablation
Lead Sponsor:
Johannes Gutenberg University Mainz
Conditions:
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study investigates impact of adenosine versus AF inducibility and subsequent termination on the acute and long-term outcome of paroxysmal AF ablation.
Detailed Description
Despite intensive efforts to increase single procedure success rates of pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (AF), an arrhythmia-free surveillance has not raised beyond 80...
Eligibility Criteria
Inclusion
- patients with paroxysmal AF
- de-novo AF ablation
- age \> 18 years
Exclusion
- persistent AF
- previous cardioversion
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT02238392
Start Date
January 1 2012
End Date
June 1 2014
Last Update
September 12 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Mainz, Department of Medicine II
Mainz, Germany, 55131